Mycotopia Therapies Performance
| TPIADelisted Stock | USD 0.02 0 14.29% |
The company secures a Beta (Market Risk) of 1.89, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mycotopia Therapies will likely underperform. Mycotopia Therapies right now secures a risk of 0.0%. Please verify Mycotopia Therapies standard deviation, value at risk, kurtosis, as well as the relationship between the sortino ratio and semi variance , to decide if Mycotopia Therapies will be following its current price movements.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Mycotopia Therapies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong forward indicators, Mycotopia Therapies is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 57.4 K | |
| Total Cashflows From Investing Activities | -2746.00 |
Mycotopia |
Mycotopia Therapies Relative Risk vs. Return Landscape
If you would invest 1.60 in Mycotopia Therapies on October 16, 2025 and sell it today you would earn a total of 0.00 from holding Mycotopia Therapies or generate 0.0% return on investment over 90 days. Mycotopia Therapies is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Mycotopia, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Mycotopia Therapies Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mycotopia Therapies' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Mycotopia Therapies, and traders can use it to determine the average amount a Mycotopia Therapies' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| TPIA |
Based on monthly moving average Mycotopia Therapies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mycotopia Therapies by adding Mycotopia Therapies to a well-diversified portfolio.
Mycotopia Therapies Fundamentals Growth
Mycotopia Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Mycotopia Therapies, and Mycotopia Therapies fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mycotopia Pink Sheet performance.
| Return On Equity | -58.61 | |||
| Return On Asset | -1.36 | |||
| Current Valuation | 3.13 M | |||
| Shares Outstanding | 14.72 M | |||
| Price To Book | 11.76 X | |||
| EBITDA | (2.68 M) | |||
| Cash And Equivalents | 783.38 K | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 623.62 K | |||
| Debt To Equity | 1.53 % | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (235.48 K) | |||
| Earnings Per Share | (0.28) X | |||
| Total Asset | 1.27 M | |||
About Mycotopia Therapies Performance
By analyzing Mycotopia Therapies' fundamental ratios, stakeholders can gain valuable insights into Mycotopia Therapies' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mycotopia Therapies has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mycotopia Therapies has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Mycotopia Therapies, Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, severe anxiety, depression, palliative care, and serotonin syndrome. Mycotopia Therapies operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 1 people.Things to note about Mycotopia Therapies performance evaluation
Checking the ongoing alerts about Mycotopia Therapies for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Mycotopia Therapies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mycotopia Therapies is not yet fully synchronised with the market data | |
| Mycotopia Therapies has some characteristics of a very speculative penny stock | |
| Mycotopia Therapies has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (2.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Mycotopia Therapies currently holds about 783.38 K in cash with (235.48 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 75.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Mycotopia Therapies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mycotopia Therapies' stock is overvalued or undervalued compared to its peers.
- Examining Mycotopia Therapies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mycotopia Therapies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mycotopia Therapies' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mycotopia Therapies' pink sheet. These opinions can provide insight into Mycotopia Therapies' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Mycotopia Pink Sheet
If you are still planning to invest in Mycotopia Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mycotopia Therapies' history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |